image
Mersana Therapeutics, Inc. MRSN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.21
-12.3 %
$ 271 M
Market Cap
-2.6
P/E
BALANCE SHEET
226 M ASSETS
-32.39%
Growth Rates
1Year -32.39%
3Years -6.14%
5Years 23.56%
7Years 11.56%
10Years 0.00%
189 M LIABILITIES
-21.93%
Growth Rates
1Year -21.93%
3Years 61.02%
5Years 22.10%
7Years 2.36%
10Years 0.00%
36.9 M EQUITY
-59.91%
Growth Rates
1Year -59.91%
3Years -45.51%
5Years 33.22%
7Years 15.02%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Mersana Therapeutics, Inc.
image
Current Assets 214 M
Cash & Short-Term Investments 209 M
Receivables 0
Other Current Assets 4.97 M
Non-Current Assets 12 M
Long-Term Investments 0
PP&E 11.5 M
Other Non-Current Assets 478 K
Current Liabilities 63.6 M
Accounts Payable 7.32 M
Short-Term Debt 5.48 M
Other Current Liabilities 50.8 M
Non-Current Liabilities 126 M
Long-Term Debt 28.4 M
Other Non-Current Liabilities 97.2 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
ASSETS
Cash & Cash Equivalents 174.6 280.7 177.9 255.1 62.4 59.6 26.6 100.3 11.5
Short Term Investments 34.5 151.8 0 0 37.4 10.5 88.1 0 0
Receivables 0 30.0 0 0 0 0.5 0.8 1.1 0.6
Inventory 0 0 0 0 0 (4.2) 1 0 1
Other Current Assets 5.0 8.5 21.9 3.5 3.1 7.4 4.0 0.8 0.6
Total Current Assets 214.1 319.2 188.9 258.6 101.3 70.1 117.5 102.2 12.8
PP&E 11.5 14.5 14.9 12.7 4.8 2.7 2.3 2.5 1.3
Intangible Assets 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0.5 0.5 321 0.3 0.4 10.5 0.3 0
Other Long Term Assets 0.5 0.2 1.9 2.2 1.1 5.3 0.4 0.1 0.4
Other Assets 0 0 0 0 0 0 0 0 0
Total Assets 226.1 334.3 206.1 273.4 107.5 78.5 130.7 105.1 14.4
LIABILITIES
Accounts Payable 7.3 14.0 12.3 8.3 7.3 10.7 3.1 2.1 2.0
Short Term Debt 5.5 3.0 2.5 1.5 2.9 0 0 0 0
Other Current Liabilities 22.7 44.2 29.0 16.2 9.1 12.5 7.2 3.6 1.7
Total Current Liabilities 63.6 91.5 47.5 30.0 24.1 69.4 31.9 28.4 10.7
Long Term Debt 28.4 33.5 35.9 15.1 4.9 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0
Other Liabilities 1 K 0.2 1.0 0.2 0.3 0.3 67 K 94.7 36.3
Total Liabilities 189.2 242.3 84.4 45.3 29.2 69.7 60.7 160.7 57.1
EQUITY
Common Stock 12 K 11 K 7 K 7 K 5 K 3 K 3 K 1 K 1 K
Retained Earnings (826.4) (654.7) (450.5) (280.4) (192.4) (164.2) (97.9) (59.2) (45.5)
Other Accumulative Comprehensive Income/Loss 11 K (0.2) 0 0 25 K 8 K (0.1) (4.2) (3.6)
Total Equity 36.9 92.1 121.7 228.1 78.3 8.8 70.0 (55.6) (42.7)
Total Liabilities and Equity 226.1 334.3 206.1 273.4 107.5 78.5 130.7 105.1 14.4
SHARES OUTSTANDING
Common Shares Outstanding 116.1 93.7 70.6 61.5 43.4 23.0 12.0 17.5 17.5